Others - Outcome without intimation
Deal
Deal value₹48 Cr
Deal vs businessRights issue of ₹48 Cr vs TTM revenue of ₹12 Cr and Net Worth of ₹9 Cr
Execution period—
Fundamental gradeD
AI projections
Revenue uplift (yr1 / steady)50.0% / 150.0%
EPS uplift-40.0%
Upside base / bull / bear-20.0% / 25.0% / -50.0%
Horizon12-24 months
Realized market record
Entry — next-day open (29 Jul 2026)₹1.18
Latest close (16 Sep 2026)₹1.38
Return since+16.9%
α vs Smallcap 250+17.6%
Positives
- Substantial equity capital infusion of ₹48 Cr expanding net worth from ₹9 Cr to ₹57 Cr
- Enhanced lending capacity to scale interest-earning assets in the NBFC segment
Risks
- Massive equity dilution (4 new shares for every 1 existing share, issuing 40 Cr shares at ₹1.20)
- Critically low promoter holding of 3.59% raising significant governance and skin-in-the-game concerns
- Loss-making operations with TTM net profit of -₹3.23 Cr and erratic quarterly revenue reporting
- High risk of non-performing assets (NPAs) if capital is deployed rapidly without robust credit risk controls
Governance flags
- Promoter holding is extremely low at 3.59%
- Erratic financial reporting including negative revenue reported in Q2 FY26 (-₹0.04 Cr)
Full AI brief
Minolta Finance (532164) - Rights Issue Analysis
Analysis Date: 2026-07-28
Current Price: ₹1.1 | Market Cap: ₹50 Cr | P/B: 5.4x
1. Announcement Overview & Financial Impact
Minolta Finance announced a revision of the renunciation deadline (to Aug 11, 2026) for its massive ₹48 Cr Rights Issue. The issue consists of 40 Cr equity shares at ₹1.20 per share (4:1 ratio).
- Capital Delta: Net Worth increases from ₹9 Cr to ₹57 Cr upon full subscription.
- Dilution Impact: Issuing 40 Cr shares on an existing estimated share base of ~10 Cr shares represents a 400% equity expansion.
- EPS Impact: While interest income will rise as loan capital expands, EPS will be severely diluted in the short-to-medium term. TTM Net Profit stands at -₹3.23 Cr. Assuming a 10% NIM on fresh capital (₹4.8 Cr incremental PAT), total PAT would reach ~₹1.6 Cr. Divided by the post-issue share count of ~50 Cr shares, EPS would be ~₹0.03, reflecting substantial dilution relative to book value.
2. Fundamental & Governance Quality
- Promoter Holding: 3.59% (CRITICAL RISK). Extremely low promoter skin-in-the-game.
- Profitability: TTM Revenue of ₹12 Cr with TTM PAT of -₹3.23 Cr. The company reported a negative revenue quarter in Sep 2025 (-₹0.04 Cr), indicating lack of core business stability.
- Valuation: Trading at P/B 5.4x despite zero/negative ROE and structural operational weak points.
3. Scenario Valuation
- Bull Case (+25%): Full capital deployment at healthy NIMs with no major bad loans, lifting PAT to ₹3 Cr; market re-rates stock to ₹1.38.
- Base Case (-20%): Dilution pressure and slow capital deployment drive the stock toward adjusted book value of ~₹0.88.
- Bear Case (-50%): Asset quality stress or incomplete issue subscription leads price to drop to ₹0.55.
4. Verdict & Rationale
Verdict: UNLIKELY (Score: 22/100)
Despite the large scale of the fundraise relative to current net worth, the severe share dilution, weak underlying financial performance, and critically low promoter holding (3.59%) create unfavorable risk-reward dynamics.
Analysis as of 2026-07-28 (price ₹1.08) ·
AI research, not investment advice.
FollowTelegram
